Nexalin Device
Insomnia
Key Facts
About Nexalin Technology
Nexalin Technology is a neuroscience-focused medical device company on a mission to address the global mental health epidemic with its non-invasive neuromodulation platform. Its core achievement is the development of a patented, frequency-based waveform device designed to treat anxiety and insomnia by normalizing neurochemical imbalances without medication. The company's strategy involves pursuing FDA clearance via a pivotal trial, expanding its commercial footprint through a dual-channel model targeting providers and patients, and leveraging an AI-driven virtual clinic to scale access. Nexalin is positioning itself as a leader in the next generation of decentralized, digital brain health therapeutics.
View full company profileAbout Nexalin Technology
Nexalin Technology is a neuroscience-focused medical device company on a mission to address the global mental health epidemic with its non-invasive neuromodulation platform. Its core achievement is the development of a patented, frequency-based waveform device designed to treat anxiety and insomnia by normalizing neurochemical imbalances without medication. The company's strategy involves pursuing FDA clearance via a pivotal trial, expanding its commercial footprint through a dual-channel model targeting providers and patients, and leveraging an AI-driven virtual clinic to scale access. Nexalin is positioning itself as a leader in the next generation of decentralized, digital brain health therapeutics.
View full company profileAbout Nexalin Technology
Nexalin Technology is a neuroscience-focused medical device company on a mission to address the global mental health epidemic with its non-invasive neuromodulation platform. Its core achievement is the development of a patented, frequency-based waveform device designed to treat anxiety and insomnia by normalizing neurochemical imbalances without medication. The company's strategy involves pursuing FDA clearance via a pivotal trial, expanding its commercial footprint through a dual-channel model targeting providers and patients, and leveraging an AI-driven virtual clinic to scale access. Nexalin is positioning itself as a leader in the next generation of decentralized, digital brain health therapeutics.
View full company profileAbout Nexalin Technology
Nexalin Technology is a neuroscience-focused medical device company on a mission to address the global mental health epidemic with its non-invasive neuromodulation platform. Its core achievement is the development of a patented, frequency-based waveform device designed to treat anxiety and insomnia by normalizing neurochemical imbalances without medication. The company's strategy involves pursuing FDA clearance via a pivotal trial, expanding its commercial footprint through a dual-channel model targeting providers and patients, and leveraging an AI-driven virtual clinic to scale access. Nexalin is positioning itself as a leader in the next generation of decentralized, digital brain health therapeutics.
View full company profileTherapeutic Areas
Other Insomnia Drugs
| Drug | Company | Phase |
|---|---|---|
| Cannabidiol Soft‑Gel Capsule | Avecho Biotechnology | Phase 3 |
| SILENOR | Currax Pharmaceuticals | Approved |
| CLM-IN01 | Closed Loop Medicine | Pre-commercial (UKCA/CE marked) |
| Levroso Long (Diphenhydramine/Melatonin) | NovaMedica | Approved |
| Insomnia Studies | Pacific Clinical Research Medical Group | Phase 2/3 |
| HS-10384 | Hansoh Pharma | Phase III |
| CEL-101 (C-122) | Celon Pharma | Phase II |
| CGS-2 | Canopy Growth | Phase II |